SINGLE-SESSION BILATERAL REDUCED-SETTINGS PHOTODYNAMIC THERAPY FOR BILATERAL CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

por Pauleikhoff, Laurenz J.B., Diederen, Roselie M.H., Feenstra, Helena M.A., Schlingemann, Reinier O., van Dijk, Elon H.C., Boon, Camiel J.F.
Publicado 2023

Long-term follow-up of chronic central serous chorioretinopathy patients after primary treatment of oral eplerenone or half-dose photodynamic therapy and crossover treatment: SPECT...

por Feenstra, Helena M. A., van Dijk, Elon H. C., van Rijssen, Thomas J., Tsonaka, Roula, Diederen, Roselie M. H., Hoyng, Carel B., Schlingemann, Reinier O., Boon, Camiel J. F.
Publicado 2022

INCREASING EVIDENCE FOR THE SAFETY OF FOVEA-INVOLVING HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY

por Feenstra, Helena M. A., Diederen, Roselie M. H., Lamme, Martine J. C. M., Tsonaka, Roula, Fauser, Sascha, Yzer, Suzanne, van Rijssen, Thomas, Gkika, Theodora, Downes, Susan M., Schlingemann, Reinier O., Hoyng, Carel B., van Dijk, Elon H. C., Boon, Camiel J. F.
Publicado 2023